Celgene Ended Theranos Deal Early Over Bad Data, Jury Told

By Dorothy Atkins · September 29, 2021, 10:30 PM EDT

A former Celgene senior scientist testified in ex-Theranos CEO Elizabeth Holmes' criminal fraud trial Wednesday that the pharmaceutical company cut short its deal with Theranos to help it in clinical trial...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

USA v. Holmes et al

Case Number

5:18-cr-00258

Court

California Northern

Nature of Suit

Date Filed

June 14, 2018